GlaxoSmithKline (GSK), the world's fourth largest drug maker, has entered into an equal joint venture agreement with Biological-E Ltd., a vaccines company based in Hyderabad, recently. The report has unveiled that the two companies are giving a shot to a six-in-one vaccine.
The companies would conduct a deep research as they are aiming at developing such a combination paediatric vaccine that protects children in developing nations like India. It is being hoped that the combination vaccine could fight not only polio, but other infectious diseases as well.
To read the original article: GSK Signs Agreement with Biological-E for Six-in-One Polio Vaccine | French Tribune
